SELLAS Life Sciences Group, Inc.SLSEarnings & Financial Report
Nasdaq
SLS Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-7.1M
Net Profit
$-6.8M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.06
SELLAS Life Sciences Group, Inc. Q3 2025 Financial Summary
SELLAS Life Sciences Group, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-6.8M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-6.8M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
SELLAS Life Sciences Group, Inc. Annual Revenue by Year
SELLAS Life Sciences Group, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $79.0K).
| Year | Annual Revenue |
|---|---|
| 2024 | $79.0K |
| 2023 | $0 |
| 2022 | $1.0M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $79000 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $6.2M | $24.4M | $15.1M | $26.5M | $19.4M | $35.0M | $32.3M | $51.6M |
| Liabilities | $14.2M | $14.8M | $12.2M | $10.6M | $10.0M | $7.2M | $6.2M | $5.9M |
| Equity | $-8.0M | $9.7M | $2.9M | $15.9M | $9.5M | $27.8M | $26.1M | $45.6M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-4.8M | $-10.8M | $-9.7M | $-7.8M | $-7.2M | $-9.1M | $-7.3M | $-7.1M |